Impact of Medical Therapy on Pulmonary Hypertension in Patients With Congestive Heart Failure Awaiting Cardiac Transplantation
- 15 August 1996
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (4) , 440-443
- https://doi.org/10.1016/s0002-9149(96)00334-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Improvement in exercise capacity of candidates awaiting heart transplantationJournal of the American College of Cardiology, 1995
- Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1993
- Sudden death in idiopathic dilated cardiomyopathyAmerican Heart Journal, 1992
- Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk groupJournal of the American College of Cardiology, 1992
- Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.Circulation, 1991
- Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1990
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failureThe American Journal of Cardiology, 1982